Nutrition: Can ghrelin improve appetite in uremic wasting?

Nature Reviews Nephrology

Volumn 5, Issue 12, 2009, Pages 672-673

  Carrero, Juan Jess ^a   Stenvinkel, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL GHRELIN; ANOREXIGENIC AGENT; APPETITE STIMULANT; DESACYL GHRELIN; GHRELIN; GHRELIN RECEPTOR; GROWTH HORMONE; HYDROCORTISONE; NEUROPEPTIDE; UNCLASSIFIED DRUG;

ANOREXIA; APPETITE; CALORIC INTAKE; CANCER INCIDENCE; CARCINOGENESIS; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DRUG EFFECT; ENERGY BALANCE; ENERGY EXPENDITURE; FOLLOW UP; FOOD INTAKE; GROWTH HORMONE BLOOD LEVEL; HEART FAILURE; HEMODIALYSIS PATIENT; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOLYSIS; LONG TERM CARE; MALNUTRITION; MORTALITY; NERVE CONDUCTION; NONHUMAN; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE; RISK FACTOR; SHORT SURVEY; STOMACH EMPTYING; SYMPATHETIC NERVE; UREMIA; VASODILATATION; WASTING SYNDROME;

APPETITIVE BEHAVIOR; GHRELIN; HUMANS; PROTEIN-ENERGY MALNUTRITION; RENAL INSUFFICIENCY, CHRONIC; UREMIA;

EID: 73849125976     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2009.171     Document Type: Short Survey

References (13)

1. Carrero, J. J. identification of patients with eating disorders: clinical and biochemical signs of appetite loss in dialysis patients. J. Ren. Nutr. 19, 10-15 (2009).
2. wynne, K. et al. subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized placebo-controlled trial. J. Am. Soc. Nephrol. 16, 2111-2118 (2005).
3. Ashby, D. R. et al. sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int. 76, 199-206 (2009).
4. Asakawa, A. et al. stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 54, 18-24 (2005).
5. Rodriguez Ayala, e. et al. Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study. Nephrol. Dial. Transpl. 19, 421-426 (2004).
6. Ashitani, J.-i., Matsumoto, n. & nakazato, M. Ghrelin and its therapeutic potential for cachectic patients. Peptides doi:10.1016/ j.peptides.2009.07.002
7. Yoshimoto, A. et al. Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J. Am. Soc. Nephrol. 13, 2748-2752 (2002).
8. nagaya, n. et al. effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 110, 3674-3679 (2004).
9. DeBoer, M. D. et al. Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology 149, 827-835 (2008).
10. Murata, M. et al. Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J. Biol. Chem. 277, 5667-5674 (2002).
11. vestergaard, e. T. et al. Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of growth hormone signaling. Diabetes 57, 3205-3210 (2008).
12. Barazzoni, R. et al. Higher total ghrelin levels are associated with higher insulin-mediated glucose disposal in non-diabetic maintenance hemodialysis patients. Clin. Nutr. 27, 142-149 (2008).
13. Theander-Carrillo, C. et al. Ghrelin action in the brain controls adipocyte metabolism. J. Clin. Invest. 116, 1983-1993 (2006).